Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Christopher Ford to Dopamine

This is a "connection" page, showing publications Christopher Ford has written about Dopamine.

 
Connection Strength
  
 
 
5.695
  
  1. Nielsen BE, Ford CP. Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors. Sci Adv. 2024 Nov 22; 10(47):eadp6301.
    View in: PubMed
    Score: 0.750
  2. Zych SM, Ford CP. Divergent properties and independent regulation of striatal dopamine and GABA co-transmission. Cell Rep. 2022 05 17; 39(7):110823.
    View in: PubMed
    Score: 0.630
  3. Cai Y, Ford CP. Dopamine Cells Differentially Regulate Striatal Cholinergic Transmission across Regions through Corelease of Dopamine and Glutamate. Cell Rep. 2018 12 11; 25(11):3148-3157.e3.
    View in: PubMed
    Score: 0.497
  4. Mamaligas AA, Ford CP. Revealing a Role for NMDA Receptors in Regulating STN Inputs following the Loss of Dopamine. Neuron. 2017 Sep 13; 95(6):1227-1229.
    View in: PubMed
    Score: 0.456
  5. Marcott PF, Mamaligas AA, Ford CP. Phasic dopamine release drives rapid activation of striatal D2-receptors. Neuron. 2014 Oct 01; 84(1):164-176.
    View in: PubMed
    Score: 0.370
  6. Courtney NA, Ford CP. The timing of dopamine- and noradrenaline-mediated transmission reflects underlying differences in the extent of spillover and pooling. J Neurosci. 2014 May 28; 34(22):7645-56.
    View in: PubMed
    Score: 0.363
  7. Courtney NA, Mamaligas AA, Ford CP. Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing. J Neurosci. 2012 Sep 26; 32(39):13520-8.
    View in: PubMed
    Score: 0.323
  8. Ford CP, Gantz SC, Phillips PE, Williams JT. Control of extracellular dopamine at dendrite and axon terminals. J Neurosci. 2010 May 19; 30(20):6975-83.
    View in: PubMed
    Score: 0.274
  9. Ford CP, Phillips PE, Williams JT. The time course of dopamine transmission in the ventral tegmental area. J Neurosci. 2009 Oct 21; 29(42):13344-52.
    View in: PubMed
    Score: 0.264
  10. Ford CP, Williams JT. Mesoprefrontal dopamine neurons distinguish themselves. Neuron. 2008 Mar 13; 57(5):631-2.
    View in: PubMed
    Score: 0.236
  11. Ford CP, Beckstead MJ, Williams JT. Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents. J Neurophysiol. 2007 Jan; 97(1):883-91.
    View in: PubMed
    Score: 0.215
  12. Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci. 2006 Mar 08; 26(10):2788-97.
    View in: PubMed
    Score: 0.205
  13. Labouesse MA, Wilhelm M, Kagiampaki Z, Yee AG, Denis R, Harada M, Gresch A, Marinescu AM, Otomo K, Curreli S, Serratosa Capdevila L, Zhou X, Cola RB, Ravotto L, Gl?ck C, Cherepanov S, Weber B, Zhou X, Katner J, Svensson KA, Fellin T, Trudeau LE, Ford CP, Sych Y, Patriarchi T. A chemogenetic approach for dopamine imaging with tunable sensitivity. Nat Commun. 2024 Jul 02; 15(1):5551.
    View in: PubMed
    Score: 0.183
  14. Jain S, Yee AG, Maas J, Gierok S, Xu H, Stansil J, Eriksen J, Nelson AB, Silm K, Ford CP, Edwards RH. Adaptor protein-3 produces synaptic vesicles that release phasic dopamine. Proc Natl Acad Sci U S A. 2023 10 17; 120(42):e2309843120.
    View in: PubMed
    Score: 0.174
  15. Rodriguez-Contreras D, Gong S, Lebowitz JJ, Fedorov LM, Asad N, Dore TM, Phillips TJ, Ford CP, Williams JT, Neve KA. Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation DRD2I212F. Mol Pharmacol. 2023 03; 103(3):188-198.
    View in: PubMed
    Score: 0.164
  16. Cai Y, Nielsen BE, Boxer EE, Aoto J, Ford CP. Loss of nigral excitation of cholinergic interneurons contributes to parkinsonian motor impairments. Neuron. 2021 04 07; 109(7):1137-1149.e5.
    View in: PubMed
    Score: 0.145
  17. Silm K, Yang J, Marcott PF, Asensio CS, Eriksen J, Guthrie DA, Newman AH, Ford CP, Edwards RH. Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties. Neuron. 2019 05 22; 102(4):786-800.e5.
    View in: PubMed
    Score: 0.127
  18. Marcott PF, Gong S, Donthamsetti P, Grinnell SG, Nelson MN, Newman AH, Birnbaumer L, Martemyanov KA, Javitch JA, Ford CP. Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens. Neuron. 2018 05 02; 98(3):575-587.e4.
    View in: PubMed
    Score: 0.119
  19. Gantz SC, Ford CP, Neve KA, Williams JT. Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway. J Neurosci. 2011 Aug 31; 31(35):12629-37.
    View in: PubMed
    Score: 0.075
  20. Bender KJ, Ford CP, Trussell LO. Dopaminergic modulation of axon initial segment calcium channels regulates action potential initiation. Neuron. 2010 Nov 04; 68(3):500-11.
    View in: PubMed
    Score: 0.071
  21. Beckstead MJ, Ford CP, Phillips PE, Williams JT. Presynaptic regulation of dendrodendritic dopamine transmission. Eur J Neurosci. 2007 Sep; 26(6):1479-88.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)